TR201722102A2 - Levodropropizin İçeren Farmasötik Bir Ürün - Google Patents
Levodropropizin İçeren Farmasötik Bir Ürün Download PDFInfo
- Publication number
- TR201722102A2 TR201722102A2 TR2017/22102A TR201722102A TR201722102A2 TR 201722102 A2 TR201722102 A2 TR 201722102A2 TR 2017/22102 A TR2017/22102 A TR 2017/22102A TR 201722102 A TR201722102 A TR 201722102A TR 201722102 A2 TR201722102 A2 TR 201722102A2
- Authority
- TR
- Turkey
- Prior art keywords
- pharmaceutical product
- product containing
- levodropropizine
- containing levodropropizine
- cough
- Prior art date
Links
- PTVWPYVOOKLBCG-ZDUSSCGKSA-N levodropropizine Chemical compound C1CN(C[C@H](O)CO)CCN1C1=CC=CC=C1 PTVWPYVOOKLBCG-ZDUSSCGKSA-N 0.000 title abstract 2
- 229960002265 levodropropizine Drugs 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 229940127557 pharmaceutical product Drugs 0.000 title abstract 2
- 206010011224 Cough Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000007910 chewable tablet Substances 0.000 abstract 1
- 238000002636 symptomatic treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Abstract
Buluş; öksürüğün semptomatik tedavisinde kullanılmak üzere; levodropropizin etken maddesi içeren çiğneme tableti formunda oral bir farmasötik ürün ile ilgilidir.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2017/22102A TR201722102A2 (tr) | 2017-12-27 | 2017-12-27 | Levodropropizin İçeren Farmasötik Bir Ürün |
PCT/TR2018/050654 WO2019132823A1 (en) | 2017-12-27 | 2018-11-05 | A pharmaceutical product comprising levodropropizine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2017/22102A TR201722102A2 (tr) | 2017-12-27 | 2017-12-27 | Levodropropizin İçeren Farmasötik Bir Ürün |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201722102A2 true TR201722102A2 (tr) | 2019-07-22 |
Family
ID=67067912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2017/22102A TR201722102A2 (tr) | 2017-12-27 | 2017-12-27 | Levodropropizin İçeren Farmasötik Bir Ürün |
Country Status (2)
Country | Link |
---|---|
TR (1) | TR201722102A2 (tr) |
WO (1) | WO2019132823A1 (tr) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100544722C (zh) * | 2006-10-12 | 2009-09-30 | 朱志宏 | 一种口腔内使用的左羟丙哌嗪药物组合物 |
CN101176730A (zh) * | 2006-11-07 | 2008-05-14 | 朱志宏 | 一种药物组合物及其制备工艺 |
-
2017
- 2017-12-27 TR TR2017/22102A patent/TR201722102A2/tr unknown
-
2018
- 2018-11-05 WO PCT/TR2018/050654 patent/WO2019132823A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2019132823A1 (en) | 2019-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122730T1 (el) | 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων | |
MY196173A (en) | Cot Modulators And Methods Of Use Thereof | |
SG10201810985XA (en) | Tofacitinib oral sustained release dosage forms | |
BR112015023417A2 (pt) | compostos heterocíclicos e seus usos | |
MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
MX2016015093A (es) | Derivados de acido boronico y sus usos terapeuticos. | |
CL2018001199A1 (es) | Composiciones terapéuticas para el tratamiento del virus de inmunodeficiencia humana | |
DOP2017000306A (es) | Formulaciones farmacéuticas que contienen tenofovir y emtricitabina | |
EA201792591A1 (ru) | Фармацевтические препараты | |
MY157673A (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
PH12015500823A1 (en) | Modified release formulations for oprozomib | |
CL2016001094A1 (es) | Silicato de zirconio microporoso para el tratamiento de hipercalemia. | |
ZA202006377B (en) | Boronic acid derivatives and therapeutic uses thereof | |
MX2016002560A (es) | Forma de dosificacion unitaria que comprende emtricitabina, tenofovir, darunavir y ritonavir y un comprimido monolitico que comprende darunavir y ritonavir. | |
UY35690A (es) | Composiciones farmacéuticas de ranolazina y dronedarona | |
EA201991286A1 (ru) | Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин | |
TR201722102A2 (tr) | Levodropropizin İçeren Farmasötik Bir Ürün | |
MX370184B (es) | Composición farmacéutica que comprende fingolimod. | |
CL2016000182A1 (es) | Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación | |
TR201821115A2 (tr) | Montelukast ve levoseti̇ri̇zi̇n i̇çeren farmasöti̇k bi̇leşi̇m | |
TR201815617A2 (tr) | Deksketoprofen içeren bir formülasyon. | |
WO2019004984A3 (en) | PHARMACEUTICAL FORMULATION COMPRISING CHOLECALCIFEROL | |
UA113442C2 (xx) | Ентеросорбент | |
TR201818990A2 (tr) | Sefdi̇ni̇r i̇çeren tablet formülasyonu | |
UA120295U (uk) | Лікарській засіб антитромбоцитарної дії |